These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 19206150)
1. JNK is constitutively active in mantle cell lymphoma: cell cycle deregulation and polyploidy by JNK inhibitor SP600125. Wang M; Atayar C; Rosati S; Bosga-Bouwer A; Kluin P; Visser L J Pathol; 2009 May; 218(1):95-103. PubMed ID: 19206150 [TBL] [Abstract][Full Text] [Related]
2. Induction of endoreduplication by a JNK inhibitor SP600125 in human lung carcinoma A 549 cells. Miyamoto-Yamasaki Y; Yamasaki M; Tachibana H; Yamada K Cell Biol Int; 2007 Dec; 31(12):1501-6. PubMed ID: 17904874 [TBL] [Abstract][Full Text] [Related]
3. Bcl-2 overexpression attenuates SP600125-induced apoptosis in human leukemia U937 cells. Moon DO; Kim MO; Choi YH; Kim ND; Chang JH; Kim GY Cancer Lett; 2008 Jun; 264(2):316-25. PubMed ID: 18343029 [TBL] [Abstract][Full Text] [Related]
4. Growth suppression of human mast cells expressing constitutively active c-kit receptors by JNK inhibitor SP600125. Wang B; Tsukada J; Higashi T; Mizobe T; Matsuura A; Mouri F; Sawamukai N; Ra C; Tanaka Y Genes Cells; 2006 Sep; 11(9):983-92. PubMed ID: 16923120 [TBL] [Abstract][Full Text] [Related]
5. Involvement of c-Jun N-terminal kinase in G2/M arrest and FasL-mediated apoptosis induced by a novel indoloquinoline derivative, IQDMA, in K562 cells. Yang SH; Chien CM; Lu CM; Chen YL; Chang LS; Lin SR Leuk Res; 2007 Oct; 31(10):1413-20. PubMed ID: 17397922 [TBL] [Abstract][Full Text] [Related]
6. JNK inhibitor SP600125 promotes the formation of polymerized tubulin, leading to G2/M phase arrest, endoreduplication, and delayed apoptosis. Moon DO; Kim MO; Kang CH; Lee JD; Choi YH; Kim GY Exp Mol Med; 2009 Sep; 41(9):665-77. PubMed ID: 19478553 [TBL] [Abstract][Full Text] [Related]
7. Novel indoloquinoline derivative, IQDMA, induces G(2)/M phase arrest and apoptosis in A549 cells through JNK/p38 MAPK signaling activation. Su JC; Lin KL; Chien CM; Lu CM; Chen YL; Chang LS; Lin SR Life Sci; 2009 Sep; 85(13-14):505-16. PubMed ID: 19699753 [TBL] [Abstract][Full Text] [Related]
8. JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis. Alexaki VI; Javelaud D; Mauviel A Pigment Cell Melanoma Res; 2008 Aug; 21(4):429-38. PubMed ID: 18541008 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. Mingo-Sion AM; Marietta PM; Koller E; Wolf DM; Van Den Berg CL Oncogene; 2004 Jan; 23(2):596-604. PubMed ID: 14724588 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest. Kuntzen C; Sonuc N; De Toni EN; Opelz C; Mucha SR; Gerbes AL; Eichhorst ST Cancer Res; 2005 Aug; 65(15):6780-8. PubMed ID: 16061660 [TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma. Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270 [TBL] [Abstract][Full Text] [Related]
12. Induction of G2/M arrest, endoreduplication, and apoptosis by actin depolymerization agent pextenotoxin-2 in human leukemia cells, involving activation of ERK and JNK. Moon DO; Kim MO; Kang SH; Lee KJ; Heo MS; Choi KS; Choi YH; Kim GY Biochem Pharmacol; 2008 Aug; 76(3):312-21. PubMed ID: 18571148 [TBL] [Abstract][Full Text] [Related]
13. Responses in mantle cell lymphoma cells to SNS-032 depend on the biological context of each cell line. Chen R; Chubb S; Cheng T; Hawtin RE; Gandhi V; Plunkett W Cancer Res; 2010 Aug; 70(16):6587-97. PubMed ID: 20663900 [TBL] [Abstract][Full Text] [Related]
14. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679 [TBL] [Abstract][Full Text] [Related]
15. [Impact of PTEN gene knockout in human breast carcinoma MCF-7 cells on activity of JNK pathway]. Jin Y; Hu JL; Xiao L; Cui W Ai Zheng; 2008 Dec; 27(12):1239-43. PubMed ID: 19079986 [TBL] [Abstract][Full Text] [Related]
16. A JNK inhibitor SP600125 induces defective cytokinesis and enlargement in P19 embryonal carcinoma cells. Nakaya K; Ooishi R; Funaba M; Murakami M Cell Biochem Funct; 2009 Oct; 27(7):468-72. PubMed ID: 19711443 [TBL] [Abstract][Full Text] [Related]
17. The Signal Transducer and Activator of Transcription 5B (STAT5B) Gene Promotes Proliferation and Drug Resistance of Human Mantle Cell Lymphoma Cells by Activating the Akt Signaling Pathway. Zhang W; Liang X; Gong Y; Xiao C; Guo B; Yang T Med Sci Monit; 2019 Apr; 25():2599-2608. PubMed ID: 30964854 [TBL] [Abstract][Full Text] [Related]
18. Methyl Sartortuoate Inhibits Colon Cancer Cell Growth by Inducing Apoptosis and G2/M-Phase Arrest. Lan Q; Li S; Lai W; Xu H; Zhang Y; Zeng Y; Lan W; Chu Z Int J Mol Sci; 2015 Aug; 16(8):19401-18. PubMed ID: 26287184 [TBL] [Abstract][Full Text] [Related]
19. Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation. Zhang W; McQueen T; Schober W; Rassidakis G; Andreeff M; Konopleva M Leukemia; 2005 Nov; 19(11):1977-84. PubMed ID: 16151469 [TBL] [Abstract][Full Text] [Related]